Fausto Bogazzi

Fausto Bogazzi

Auto-generated profile, based on publicly available information

Fausto Bogazzi

Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 1998 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
LBLuigi Bartalena
Luigi Bartalena
CMClaudio Marcocci
Claudio Marcocci
FBFausto Bogazzi
Fausto Bogazzi
LMLuca Manetti
Luca Manetti
Maria Laura TandaMaria Laura Tanda
Maria Laura Tanda
APAldo Pinchera
Aldo Pinchera
The chief clinical characteristics of Graves' disease are hyperthyroidism and ophthalmopathy. The relation between the two and the effect of treatment for hyperthyroidism on ophthalmopathy are unclear.

1 January 1998 in European Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
TRT Rago
T Rago
PVP Vitti
P Vitti
LCL Chiovato
L Chiovato
SMS Mazzeo
S Mazzeo
ALA De Liperi
A De Liperi
APA Pinchera
A Pinchera
The aim of the present study was to establish the usefulness of conventional thyroid ultrasonography (US) and color flow-doppler (CFD) sonography in the assessment of 'cold' thyroid nodules. One hundred and four consecutive patients with thyroid nodules who were to undergo surgery were examined by US and CFD before thyroidectomy. Conventional US evaluated the presence of a halo sign, hypoechogenicity and microcalcifications. The vascular pattern on CFD was classified as follows: Type I, absence of blood flow; Type II, perinodular blood flow; Type III, marked intranodular blood flow. On histology, 30 nodules were diagnosed as malignant (carcinoma, CA) and 74 as benign nodules (BN). On US, the echographic pattern most predictive for malignancy was absent halo sign, which was found in 20/30 CA and in 17/72 BN (P = 0.0001; specificity 77.0%; sensitivity 66.6%). The most specific combination on US, absent halo sign/microcalcifications, was found in 8/30 CA and in 5/74 BN (P < 0.005; specificity 93.2%, sensitivity 26.6%). The Type III pattern on CFD was found in 20/30 CA and 38/74 BN (not statistically significant). The combination of absent halo sign on US with Type III pattern on CFD was found in 15/30 CA and in 8/74 BN (P < 0.0001; specificity 89.0%, sensitivity 50.0%). The combination of absent halo sign/microcalcifications on US with Type III pattern on CFD was the most specific combination of the two techniques, being found in 5/30 CA and in only 2/74 BN (P < 0.01; specificity 97.2%, sensitivity 16.6%). In conclusion, findings on US and CFD become highly predictive for malignancy only when multiple signs are simultaneously present in a thyroid nodule. Thus the predictive value of these techniques increases at the expense of their sensitivity. Only in a small proportion of patients with thyroid carcinoma is US and CFD information highly predictive of malignancy.

16 November 1989 in New England Journal of Medicine
Verified
Journal Article
Closed access
LBLuigi Bartalena
Luigi Bartalena
CMClaudio Marcocci
Claudio Marcocci
FBFausto Bogazzi
Fausto Bogazzi
MPMassimo Panicucci
Massimo Panicucci
ALAntonio Lepri
Antonio Lepri
APAldo Pinchera
Aldo Pinchera
We studied the effects of radioiodine treatment of hyperthyroidism due to Graves' disease on Graves' ophthalmopathy and the possible protective role of corticosteroids. Between June 1985 and June 1988, 26 patients were randomly assigned to treatment with radioiodine alone (group 1) and 26 to treatment with this agent and concomitant administration of systemic prednisone for four months (group 2). The initial dose of prednisone was 0.4 to 0.5 mg per kilogram of body weight for one month; the drug was gradually withdrawn over the next three months. All patients were evaluated at 3-month intervals for 18 months after they underwent radioiodine therapy. Ocular changes were assessed with the ophthalmopathy index; patients with moderate-to-severe changes (scores≥4) were excluded from the study.

1 February 2001 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
LBL. Bartalena
L. Bartalena
FBF. Bogazzi
F. Bogazzi
LBL. E. Braverman
L. E. Braverman
EME. Martino
E. Martino

1 June 2010 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
FBFausto Bogazzi
Fausto Bogazzi
LBLuigi Bartalena
Luigi Bartalena
EMEnio Martino
Enio Martino
Amiodarone, a benzofuranic iodine-rich antiarrhythmic drug, causes thyroid dysfunction in 15–20% of cases. Although amiodarone-induced hypothyroidism poses no particular problem, amiodarone-induced thyrotoxicosis (AIT) is a diagnostic and therapeutic challenge. There are two main forms of AIT: type 1, a form of iodine-induced hyperthyroidism, and type 2, a drug-induced destructive thyroiditis. However, mixed/indefinite forms exist that may be caused by both pathogenic mechanisms. Type 1 AIT usually occurs in abnormal thyroid glands, whereas type 2 AIT develops in apparently normal thyroid glands (or small goiters). Diagnosis of thyrotoxicosis is easy, based on the finding of increased free thyroid hormone concentrations and suppressed TSH levels. Thyroid radioactive iodine (RAI) uptake values are usually very low/suppressed in type 2 AIT, most commonly low or low-normal, but sometimes normal or increased in type 1 AIT despite the iodine load. Color flow Doppler sonography shows absent hypervascularity in type 2 and increased vascularity in type 1 AIT. Mixed/indefinite forms may have features of both AIT types. Thionamides represent the first-line treatment for type 1 AIT, but the iodine-replete gland is not very responsive; potassium perchlorate, by inhibiting thyroid iodine uptake, may increase the response to thionamides. Type 2 AIT is best treated by oral glucocorticoids. The response very much depends on the thyroid volume and the severity of thyrotoxicosis. Mixed/indefinite forms may require a combination of thionamides, potassium perchlorate, and steroids. RAI is usually not feasible in AIT due to low RAI uptake values. Thyroidectomy represents a valid option in cases resistant to medical therapy.

1 November 1989 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
LBL. Bartalena
L. Bartalena
EME. Martino
E. Martino
CMC. Marcocci
C. Marcocci
FBF. Bogazzi
F. Bogazzi
MPM. Panicucci
M. Panicucci
APA. Pinchera
A. Pinchera